Clinical Trial Update: A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety, antiviral effect, and pharmacokinetics of Celgosivir in combination with peginterferon alfa-2b and ribavirin in treatment-n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Celgosivir (celgosivir)
• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: BioWest Therapeutics Inc | Conditions: Chronic Hepatitis C | Phase 2 | Status: UNKNOWN